No Data
Express News | Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Raymond James Initiates Omega Therapeutics(OMGA.US) With Buy Rating, Announces Target Price $12
Raymond James analyst Ryan Deschner initiates coverage on $Omega Therapeutics(OMGA.US)$ with a buy rating, and sets the target price at $12.According to TipRanks data, the analyst has a success rate o
Express News | Omega Therapeutics Shares Are Trading Higher After Raymond James Initiated Coverage on the Stock With an Outperform Rating and Announced a $12 Price Target
Expert Ratings For Omega Therapeutics
Ratings for Omega Therapeutics (NASDAQ:OMGA) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table
Express News | Omega Therapeutics Inc : Raymond James Initiates Coverage With Outperform Rating; Target Price $12
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer
Flagship Pioneering and ProFound Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a...